Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT03807531Not ApplicableActive Not Recruiting

A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee

Role: collaborator

NCT05032352Terminated

Predictive Assay for Decision Making in Adjuvant Therapy

Role: collaborator

NCT03763747Not ApplicableCompleted

Scoreflex NC - Scoring PTCA Catheter

Role: collaborator

NCT02400905Not ApplicableCompleted

Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System

Role: collaborator

NCT04541576Not ApplicableWithdrawn

The Merit WRAPSODY Central Feasibility Study

Role: collaborator

NCT02224235Not ApplicableTerminated

COBRA SHIELD OCT Study

Role: collaborator

NCT02972671Not ApplicableUnknown

Trial of MiStent Compared to Xience in Japan

Role: collaborator

NCT01118117Not ApplicableCompleted

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Role: collaborator

NCT02759406Not ApplicableCompleted

Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study

Role: collaborator

All 9 trials loaded